Literature DB >> 22782705

Circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes in smoking-related interstitial fibrosis.

Huang Yuchuan1, Dai Ya, Zhang Jie, Cheng Jingqiu, Lu Yanrong, Li Dongliang, Wang Changguo, Ma Kuoyan, Liao Guangneng, Xue Fang, Tan Lanlan, Qin Bo.   

Abstract

Cigarette smoking is the major risk factor for smoking-related interstitial fibrosis (SRIF). Despite recent advances, the molecular mechanisms involved in the initiation and progression of this disease remain elusive. We found 6 months of chronic mainstream smoking exposure induced SRIF in C57 mice, which was associated with pronounced enhanced oxidative stress, bronchoalveolar inflammation and fibrosis but not apoptosis of alveolar septal cell. We used Affymetrix microRNA (miRNA) arrays to determine the temporal alteration in global gene expression of peripheral blood during the progression of diffuse pulmonary interstitial fibrosis in C57 mice. Microarray analysis revealed the upregulation of 3 miRNAs (miR-92b, miR-700 and miR-668) and the downregulation of 5 miRNAs (let-7e, miR-142-5p, miR-350, miR-19a and miR191*) in the peripheral blood of mice exposed to mainstream smoking for 1, 2, 3 and 6 months. We proposed that circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes of SRIF related interstitial fibrosis.

Entities:  

Keywords:  Smoking; biomarker; dynamic changes of pathology; miRNAs; smoking-related interstitial fibrosis

Mesh:

Substances:

Year:  2012        PMID: 22782705     DOI: 10.1177/0748233712452606

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  8 in total

1.  miRNA Expression Change in Dorsal Root Ganglia After Peripheral Nerve Injury.

Authors:  Hsueh-Ling Chang; Hung-Chen Wang; Yi-Ta Chunag; Chao-Wen Chou; I-Ling Lin; Chung-Sheng Lai; Lin-Li Chang; Kuang-I Cheng
Journal:  J Mol Neurosci       Date:  2016-12-24       Impact factor: 3.444

Review 2.  The code of non-coding RNAs in lung fibrosis.

Authors:  Huachun Cui; Na Xie; Victor J Thannickal; Gang Liu
Journal:  Cell Mol Life Sci       Date:  2015-05-31       Impact factor: 9.261

3.  Na/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblasts.

Authors:  Christopher A Drummond; Michael C Hill; Huilin Shi; Xiaoming Fan; Jeffrey X Xie; Steven T Haller; David J Kennedy; Jiang Liu; Michael R Garrett; Zijian Xie; Christopher J Cooper; Joseph I Shapiro; Jiang Tian
Journal:  Physiol Genomics       Date:  2015-12-23       Impact factor: 3.107

4.  LncRNA AK020546 protects against cardiac ischemia-reperfusion injury by sponging miR-350-3p.

Authors:  Meiqi Zhang; Kang Cheng; Huan Chen; Jianfeng Tu; Ye Shen; Lingxiao Pang; Weihua Wu; Zhenfei Yu
Journal:  Aging (Albany NY)       Date:  2021-05-13       Impact factor: 5.682

Review 5.  MicroRNAs as potential signatures of environmental exposure or effect: a systematic review.

Authors:  Karen Vrijens; Valentina Bollati; Tim S Nawrot
Journal:  Environ Health Perspect       Date:  2015-01-16       Impact factor: 9.031

6.  MiR-142-5p Protects Against 6-OHDA-Induced SH-SY5Y Cell Injury by Downregulating BECN1 and Autophagy.

Authors:  Jian Chen; Chuan Jiang; Juan Du; Chun-Li Xie
Journal:  Dose Response       Date:  2020-02-20       Impact factor: 2.658

7.  Circulating microRNA signatures in mice exposed to lipoteichoic acid.

Authors:  Ching-Hua Hsieh; Johnson Chia-Shen Yang; Jonathan Chris Jeng; Yi-Chun Chen; Tsu-Hsiang Lu; Siou-Ling Tzeng; Yi-Chan Wu; Chia-Jung Wu; Cheng-Shyuan Rau
Journal:  J Biomed Sci       Date:  2013-01-04       Impact factor: 8.410

8.  Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis.

Authors:  Amanda L Tatler; Amanda T Goodwin; Olumide Gbolahan; Gauri Saini; Joanne Porte; Alison E John; Rachel L Clifford; Shelia M Violette; Paul H Weinreb; Helen Parfrey; Paul J Wolters; Jack Gauldie; Martin Kolb; Gisli Jenkins
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.